Atrys Health SA
MAD:ATRY
Intrinsic Value
The intrinsic value of one ATRY stock under the Base Case scenario is 4.82 EUR. Compared to the current market price of 2.79 EUR, Atrys Health SA is Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Atrys Health SA
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
Atrys Health SA
Balance Sheet Decomposition
Atrys Health SA
Current Assets | 89.2m |
Cash & Short-Term Investments | 29.3m |
Receivables | 55.4m |
Other Current Assets | 4.5m |
Non-Current Assets | 495m |
Long-Term Investments | 3.2m |
PP&E | 58.2m |
Intangibles | 424.1m |
Other Non-Current Assets | 9.6m |
Free Cash Flow Analysis
Atrys Health SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Atrys Health SA
Revenue
|
212.7m
EUR
|
Cost of Revenue
|
-67.4m
EUR
|
Gross Profit
|
145.4m
EUR
|
Operating Expenses
|
-137.7m
EUR
|
Operating Income
|
7.7m
EUR
|
Other Expenses
|
-39.5m
EUR
|
Net Income
|
-31.8m
EUR
|
ATRY Profitability Score
Profitability Due Diligence
Atrys Health SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
Atrys Health SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
ATRY Solvency Score
Solvency Due Diligence
Atrys Health SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Score
Atrys Health SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ATRY Price Targets Summary
Atrys Health SA
According to Wall Street analysts, the average 1-year price target for ATRY is 6.17 EUR with a low forecast of 5.66 EUR and a high forecast of 6.83 EUR.
Dividends
Current shareholder yield for ATRY is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ATRY stock under the Base Case scenario is 4.82 EUR.
Compared to the current market price of 2.79 EUR, Atrys Health SA is Undervalued by 42%.